Showing results (131-140 of 478) with videos related to

Sort By:
Pageof 48
The Journal of Biological Chemistry|August 15, 1993
Apolipoprotein A-I domains involved in the activation of lecithin:cholesterol acyltransferase. Importance of the central domainQ H Meng, L Calabresi, J C Fruchart, et al.
Handbook of Experimental Pharmacology|April 7, 2006
FibratesR Robillard, C Fontaine, G Chinetti, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|October 14, 1994
A screening method for abnormally high lipoprotein(a) concentrations by agarose lipoprotein electrophoresisE Campos, P Fiévet, E Cacès, et al.
Atherosclerosis|October 1, 1994
Apolipoprotein A-I-containing particles and reverse cholesterol transport: evidence for connection between cholesterol efflux and atherosclerosis riskJ C Fruchart, C De Geteire, B Delfly, et al.
Medecine Tropicale : Revue Du Corps De Sante Colonial|July 1, 1990
[Arterial hypertension in Thio (New Caledonia)]P Sabbah, P Duriez, M Blanc, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux|March 1, 1996
[Intrathoracic textiloma after cardiac surgery. Apropos of a case]F Vayre, P Duriez, C Jego, et al.
Arzneimittel-Forschung|January 1, 1979
Effects of unsaturated fatty acids in phospholipids on the in vitro activation of the lipoprotein lipase and the triglyceride lipaseC Desreumaux, E Dedonder, P Dewailly, et al.
Diabetes & Metabolism|October 1, 1996
Serum Lp AI lipoprotein particles and other antiatherogenic lipid parameters in normolipidaemic obese subjectsJ M Lecerf, A Masson, J C Fruchart, et al.
The Journal of Pharmacy and Pharmacology|October 1, 1994
Location of probucol in lipoproteins inferred from compositional analysis of lipoprotein particles. An in-vitro studyJ M Bard, S Urien, J C Fruchart, et al.
Diabete & Metabolisme|April 1, 1995
Non-enzymatic glycosylation of apolipoprotein A-I and its functional consequencesC Fiévet, B Igau, R Bresson, et al.
Pageof 48